Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 3/20 | 0.33 |
| ▸ | HTR7 | P34969 | 3/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 8/20 | 0.33 |
| ▸ | DRD3 | P35462 | 8/20 | 0.33 |
| ▸ | LTA4H | P09960 | 3/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4410352 | 0.95 | KDM4E (0.35) | CCR5HTR1AHTR7MAOBHTR2A | |
| Hydrochloric Acid SCHEMBL4399154 | 0.92 | HTR7 (0.34) | HTR1AHTR7DRD3LTA4HDRD2 | |
| SCHEMBL4396521 | 0.92 | DRD2 (0.36) | MAOBHTR2ADRD3DRD2 | |
| SCHEMBL4405941 | 0.91 | HTR1A (0.36) | CCR5HTR1AHTR7MAOBHTR2A | |
| Hydrochloric Acid SCHEMBL4401793 | 0.90 | FAAH (0.32) | MAOBLTA4HKMT2A | |
| SCHEMBL913979 | 0.90 | RHEB (0.39) | HTR1AHTR7MAOBHTR2ADRD3 | |
| SCHEMBL4396334 | 0.88 | KDM4E (0.35) | MAOBHTR2ADRD3KMT2ADRD2 | |
| SCHEMBL2316977 | 0.88 | KDM4E (0.33) | CCR5MAOBHTR2ADRD3CNR1 | |
| Hydrochloric Acid SCHEMBL4406708 | 0.86 | HTR1A (0.35) | HTR1ADRD3KMT2ADRD2 | |
| SCHEMBL4405864 | 0.86 | SOS1 (0.38) | CCR5HTR1AHTR7MAOBHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1720859-B1 | CHEMOKINE RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2009-12-23 | — | — | EP | claimed |